Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06982820 · ClinicalTrials.gov registry record · NA
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
A NA study of Depressive Disorder, Major, sponsored by GrayMatters Health.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 3
- Study locations
NCT06982820 is a NA study of Depressive Disorder, Major that is actively recruiting participants, run by GrayMatters Health. The registered enrollment target is 170 participants, below the 239-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (29% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06982820, a NA study of Depressive Disorder, Major, is actively recruiting participants, sponsored by GrayMatters Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research is to learn more about a new treatment for individuals with Major Depressive Disorder (MDD) with heightened symptoms of anhedonia (i.e. loss of pleasure or interest in activities). The treatment is called Prism, and it is a software device intended for a novel form of neurofeedback training to be used in a clinic setting. During this study, the subject will use different techniques to measure brain activities, including magnetic resonance imaging (MRI) and electroencephalography (EEG).
Conditions Studied
Interventions
- DEVICE Prism Training
Study Locations (3)
Rhode Island
- Butler Hospital - Providence
Texas
- Houston Center For Advanced Psychiatric Treatment - Houston
Other
- Sheba Medical Center - Ramat Gan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2027-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06982820
The ClinicalTrials.gov registry entry for NCT06982820 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (29% lower). The listed sponsor is GrayMatters Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depressive Disorder, Major appearing as the primary indexed condition, and to 1 intervention - of which Prism Training is the first listed.
NCT06982820 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Rhode Island, Texas, Other.
Frequently Asked Questions
What is clinical trial NCT06982820 about?
NCT06982820 is a clinical study titled "Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia". The purpose of this research is to learn more about a new treatment for individuals with Major Depressive Disorder (MDD) with heightened symptoms of anhedonia (i.e. loss of pleasure or interest in activities). The treatment is called Prism, and it is a software device intended for a novel form of ne...
What is the current status of trial NCT06982820?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2025-06-25. Estimated completion is 2027-08-30.
What conditions does trial NCT06982820 study?
This clinical trial studies the following conditions: Depressive Disorder, Major.
What interventions are being tested in trial NCT06982820?
The interventions under investigation include: Prism Training (DEVICE).
Who is sponsoring clinical trial NCT06982820?
This trial is sponsored by GrayMatters Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06982820 being conducted?
This trial has 3 study locations across Rhode Island, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder, Major
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
RECRUITING · NA
-
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
RECRUITING · NA
-
Biomarkers of Depression and Treatment Response
RECRUITING · NA
-
Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
ACTIVE NOT RECRUITING · NA
-
In-person vs. Remote Wellness Support
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.